VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France

Emerg Infect Dis. 2006 Aug;12(8):1214-22. doi: 10.3201/eid1708.051547.

Abstract

VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii was responsible for an outbreak in hospitals in France. A national alert was triggered in September 2003 when 4 hospitals reported clusters of A. baumannii infection with similar susceptibility profiles. Case definitions and laboratory guidelines were disseminated, and prospective surveillance was implemented; strains were sent to a single laboratory for characterization and typing. From April 2003 through June 2004, 53 hospitals reported 290 cases of A. baumannii infection or colonization; 275 isolates were bla(VEB-1)-positive and clonally related. Cases were first reported in 5 districts of northern France, then in 10 other districts in 4 regions. Within a region, interhospital spread was associated with patient transfer. In northern France, investigation and control measures led to a reduction of reported cases after January 2004. The national alert enabled early control of new clusters, demonstrating the usefulness of early warning about antimicrobial drug resist.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections / epidemiology*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / classification
  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / enzymology
  • Acinetobacter baumannii / genetics
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Disease Outbreaks*
  • Escherichia coli Proteins
  • France / epidemiology
  • Hospitals
  • Humans
  • Infection Control / methods
  • Microbial Sensitivity Tests
  • Population Surveillance
  • beta-Lactam Resistance*
  • beta-Lactamases / metabolism*

Substances

  • Escherichia coli Proteins
  • beta-lactamase VEB-1, E coli
  • beta-Lactamases